A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors

Journal for ImmunoTherapy of Cancer - Tập 1 - Trang 1-1 - 2013
Stephen Ansell1, Donald Northfelt2, Ian Flinn3, Howard Burris3, Shira Dinner4, Victor Villalobos4, Branimir Sikic4, Lana Pilja5, Michael Yellin5, Tibor Keler5, Thomas Davis5
1Mayo Clinic, Rochester, USA
2Mayo Clinic, Scottsdale, USA.
3Sarah Cannon Research Institute, Nashville, USA
4Stanford Cancer Institute, Stanford, USA.
5Celldex Therapeutics Inc., Phillipsburg, USA

Thông tin
Thông tin xuất bản

Journal for ImmunoTherapy of Cancer

Tập 1

1-1

Thông tin tác giả